Incidence of chemotherapy-related cardiac dysfunction in cancer patients.

Hai-Wei DengRui FanYuan-Sheng ZhaiJie LiZhi-Bin HuangLong-Yun Peng

Published in: Clinical cardiology (2024)

Our meta-analysis unveiled a definitive overall incidence rate of chemotherapy-related cardiac dysfunction in cancer patients. In addition, it was found that the risk of developing this condition escalates within the initial 6 months postchemotherapy, subsequently tapering off to become statistically insignificant after a duration of 6 years.

Keyphrases

locally advanced
systematic review
risk factors
left ventricular
oxidative stress
squamous cell carcinoma
randomized controlled trial
meta analyses
radiation therapy
drug induced